US biopharma: "nearly 300 vaccines in R&D"

Article Date: 24/04/2012 06:00
US biopharma: "nearly 300 vaccines in R&D"

Vacancy Search

Quick job search

Advanced Search

Latest News

Sanofi/Regeneron's Praluent first US-approved PCSK9 inhibitor

Sanofi/Regeneron's Praluent first US-approved PCSK9 inhibitor

Allergan buys Naurex and its antidepressants for $560m

Allergan buys Naurex and its antidepressants for $560m

Is Teva eyeing up Allergan's generics for $45bn?

Is Teva eyeing up Allergan's generics for $45bn?

Astellas antifungal gets EU nod

Astellas antifungal gets EU nod

Comms agencies can be smarter and more efficient

Comms agencies can be smarter and more efficient

MHRA confirms safety of Boehringer stroke drug

MHRA confirms safety of Boehringer stroke drug

Shire's extended-release Intuniv backed for EU approval

Shire's extended-release Intuniv backed for EU approval

World's first malaria vaccine wins CHMP favour

World's first malaria vaccine wins CHMP favour

Depomed mulls over Horizon's new bid

Depomed mulls over Horizon's new bid

AZ signs up for Adherium's Smartinhaler

AZ signs up for Adherium's Smartinhaler
more news